PMC:7534795 / 31360-31575 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T161","span":{"begin":46,"end":53},"obj":"Body_part"}],"attributes":[{"id":"A161","pred":"fma_id","subj":"T161","obj":"http://purl.org/sig/ont/fma/fma82839"}],"text":"• Odd Ratio (OR) 0.372 (95% CI 0.154–0.901) • Heparin may be associated with a lower 28-day mortality rate only in patients with enhanced coagulopathy risk such as SIC score of 4 or greater (Tang, Bai, et al., 2020)"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T255","span":{"begin":138,"end":150},"obj":"Disease"}],"attributes":[{"id":"A255","pred":"mondo_id","subj":"T255","obj":"http://purl.obolibrary.org/obo/MONDO_0001531"}],"text":"• Odd Ratio (OR) 0.372 (95% CI 0.154–0.901) • Heparin may be associated with a lower 28-day mortality rate only in patients with enhanced coagulopathy risk such as SIC score of 4 or greater (Tang, Bai, et al., 2020)"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T25882","span":{"begin":77,"end":78},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"• Odd Ratio (OR) 0.372 (95% CI 0.154–0.901) • Heparin may be associated with a lower 28-day mortality rate only in patients with enhanced coagulopathy risk such as SIC score of 4 or greater (Tang, Bai, et al., 2020)"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T234","span":{"begin":46,"end":53},"obj":"Chemical"}],"attributes":[{"id":"A234","pred":"chebi_id","subj":"T234","obj":"http://purl.obolibrary.org/obo/CHEBI_28304"}],"text":"• Odd Ratio (OR) 0.372 (95% CI 0.154–0.901) • Heparin may be associated with a lower 28-day mortality rate only in patients with enhanced coagulopathy risk such as SIC score of 4 or greater (Tang, Bai, et al., 2020)"}

{"project":"LitCovid-sentences","denotations":[{"id":"T221","span":{"begin":0,"end":215},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"• Odd Ratio (OR) 0.372 (95% CI 0.154–0.901) • Heparin may be associated with a lower 28-day mortality rate only in patients with enhanced coagulopathy risk such as SIC score of 4 or greater (Tang, Bai, et al., 2020)"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T131","span":{"begin":138,"end":150},"obj":"Phenotype"}],"attributes":[{"id":"A131","pred":"hp_id","subj":"T131","obj":"http://purl.obolibrary.org/obo/HP_0003256"}],"text":"• Odd Ratio (OR) 0.372 (95% CI 0.154–0.901) • Heparin may be associated with a lower 28-day mortality rate only in patients with enhanced coagulopathy risk such as SIC score of 4 or greater (Tang, Bai, et al., 2020)"}

{"project":"2_test","denotations":[{"id":"33031856-32220112-84038872","span":{"begin":210,"end":214},"obj":"32220112"}],"text":"• Odd Ratio (OR) 0.372 (95% CI 0.154–0.901) • Heparin may be associated with a lower 28-day mortality rate only in patients with enhanced coagulopathy risk such as SIC score of 4 or greater (Tang, Bai, et al., 2020)"}

{"project":"LitCovid-PubTator","denotations":[{"id":"967","span":{"begin":115,"end":123},"obj":"Species"},{"id":"977","span":{"begin":46,"end":53},"obj":"Chemical"},{"id":"997","span":{"begin":92,"end":101},"obj":"Disease"},{"id":"998","span":{"begin":138,"end":150},"obj":"Disease"},{"id":"999","span":{"begin":164,"end":167},"obj":"Disease"}],"attributes":[{"id":"A967","pred":"tao:has_database_id","subj":"967","obj":"Tax:9606"},{"id":"A977","pred":"tao:has_database_id","subj":"977","obj":"MESH:D006493"},{"id":"A997","pred":"tao:has_database_id","subj":"997","obj":"MESH:D003643"},{"id":"A998","pred":"tao:has_database_id","subj":"998","obj":"MESH:D001778"},{"id":"A999","pred":"tao:has_database_id","subj":"999","obj":"MESH:D018805"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"• Odd Ratio (OR) 0.372 (95% CI 0.154–0.901) • Heparin may be associated with a lower 28-day mortality rate only in patients with enhanced coagulopathy risk such as SIC score of 4 or greater (Tang, Bai, et al., 2020)"}